David M. Rubenstein
Insider
First SEC filing: May 3, 2012 · Latest: May 3, 2012
Insider at
Insider transactions
0 buys (P)
3 sells (S)
Net: $-75,779,750
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2026 | CGABL | G | 100,000 | · | · | 27,299,644 Direct | -0.36% | Disposed | (price as of 2026-10-02) |
| Sept. 11, 2026 | CGABL | S | 400,000 | $42.74 | $17,096,000 | 26,899,644 Direct | -1.47% | Disposed | -63.9% (price as of 2026-10-02) |
| May 6, 2026 | MRNA | A | 9,681 | · | · | 9,681 Direct | · | Acquired | (price as of 2026-10-02) |
| May 6, 2026 | MRNA | A | 2,092 | · | · | 2,092 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2026 | MRNA | M | 8,116 | · | · | 9,643 Direct | +531.50% | Acquired | (price as of 2026-10-02) |
| April 30, 2026 | MRNA | M | 8,116 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 19, 2026 | CGABL | G | 100,000 | · | · | 27,899,644 Direct | -0.36% | Disposed | (price as of 2026-10-02) |
| March 19, 2026 | CGABL | S | 500,000 | $46.68 | $23,340,000 | 27,399,644 Direct | -1.79% | Disposed | -67.0% (price as of 2026-10-02) |
| Dec. 10, 2025 | CGABL | G | 625,000 | · | · | 28,624,644 Direct | -2.14% | Disposed | (price as of 2026-10-02) |
| Dec. 10, 2025 | CGABL | S | 625,000 | $56.55 | $35,343,750 | 27,999,644 Direct | -2.18% | Disposed | -72.7% (price as of 2026-10-02) |
| Aug. 5, 2025 | MRNA | M | 850 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 5, 2025 | MRNA | M | 850 | · | · | 1,527 Direct | +125.55% | Acquired | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | M | 677 | · | · | 677 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | M | 677 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | A | 8,116 | · | · | 8,116 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | A | 12,756 | · | · | 12,756 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 5, 2024 | MRNA | A | 677 | · | · | 677 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 5, 2024 | MRNA | A | 850 | · | · | 850 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 5, 2024 | MRNA | A | 4,065 | · | · | 4,065 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 5, 2024 | MRNA | A | 5,051 | · | · | 5,051 Direct | · | Acquired | (price as of 2026-10-02) |
| June 6, 2022 | CGABL | S | 2,000,000 | $38.67 | $77,340,000 | 29,249,644 Direct | -6.40% | Disposed | -60.1% (price as of 2026-10-02) |
| Nov. 9, 2021 | CGABL | S | 2,000,000 | $58.00 | $116,000,000 | 31,249,644 Direct | -6.02% | Disposed | -73.4% (price as of 2026-10-02) |
| Aug. 13, 2021 | CGABL | S | 4,800 | $48.86 | $234,528 | 33,249,644 Direct | -0.01% | Disposed | -68.5% (price as of 2026-10-02) |
| Aug. 13, 2021 | CGABL | S | 1,895,200 | $47.80 | $90,590,560 | 33,254,444 Direct | -5.39% | Disposed | -67.8% (price as of 2026-10-02) |
| Aug. 11, 2021 | CGABL | S | 2,100,000 | $46.46 | $97,566,000 | 35,149,644 Direct | -5.64% | Disposed | -66.8% (price as of 2026-10-02) |
| May 18, 2021 | CGABL | S | 2,000,000 | $41.76 | $83,520,000 | 37,249,644 Direct | -5.10% | Disposed | -63.1% (price as of 2026-10-02) |
| March 11, 2021 | CGABL | S | 3,000,000 | $35.80 | $107,400,000 | 39,249,644 Direct | -7.10% | Disposed | -57.0% (price as of 2026-10-02) |
| Dec. 10, 2020 | CGABL | S | 750,000 | $29.05 | $21,787,500 | 42,249,644 Direct | -1.74% | Disposed | -47.0% (price as of 2026-10-02) |
| Nov. 24, 2020 | CGABL | S | 2,000,000 | $27.30 | $54,600,000 | 42,999,644 Direct | -4.44% | Disposed | -43.6% (price as of 2026-10-02) |
| Nov. 9, 2020 | CGABL | S | 2,000,000 | $27.32 | $54,640,000 | 44,999,644 Direct | -4.26% | Disposed | -43.6% (price as of 2026-10-02) |
| Jan. 1, 2020 | CGABL | C | 46,999,644 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 1, 2020 | CGABL | C | 46,999,644 | · | · | 46,999,644 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | MRNA | Stock Option (Right to Buy) | Common Stock | $48.79 | May 6, 2036 | 9,681 | Acquired |
| May 6, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 2,092 | Acquired |
| April 30, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 8,116 | Disposed |
| Aug. 5, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 850 | Disposed |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 677 | Disposed |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 8,116 | Acquired |
| April 30, 2025 | MRNA | Stock Option (Right to Buy) | Common Stock | $28.54 | April 30, 2035 | 12,756 | Acquired |
| Aug. 5, 2024 | MRNA | Restricted Stock Units | Common Stock | · | · | 677 | Acquired |
| Aug. 5, 2024 | MRNA | Restricted Stock Units | Common Stock | · | · | 850 | Acquired |
| Aug. 5, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock | $83.75 | Aug. 5, 2034 | 4,065 | Acquired |
| Aug. 5, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock | $83.75 | Aug. 5, 2034 | 5,051 | Acquired |
| Jan. 1, 2020 | CGABL | Carlyle Holdings partnership units | Common Units Representing limited partnership interests | · | · | 46,999,644 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 3, 2012 | CGABL | Carlyle Holdings partnership units | 46,999,644 | Direct |